| Medical and Health Sciences | Lifetime | 139 | FR 1 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 93 | FR 2 | 99.98 |
| Pulmonary and Respiratory Medicine | Lifetime | 2 | FR 1 | 99.99 |
| Medical Physiology | Lifetime | 164 | FR 3 | 99.75 |
| Cardiology and Cardiovascular Medicine | Lifetime | 569 | FR 12 | 99.09 |
| Medical Genetics | Lifetime | 209 | FR 7 | 98.46 |
| Pathology and Forensic Medicine | Lifetime | 892 | FR 30 | 95.61 |
| Hepatology | Lifetime | 589 | FR 35 | 92.05 |
| Internal Medicine | Lifetime | 429 | FR 20 | 89.10 |
| Immunology and Allergy | Lifetime | 607 | FR 11 | 88.12 |
| International Economics and Trade | Lifetime | 746 | FR 29 | 80.19 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 7 | FR 1 | 99.97 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 218 | FR 5 | 98.41 |
| Medical Physiology | 2021-2025 | 387 | FR 10 | 94.65 |
| Medical Genetics | 2021-2025 | 199 | FR 8 | 91.17 |
| Ecology, Evolution, Behavior and Systematics | 2021-2025 | 588 | FR 33 | 52.32 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 1 | FR 1 | 99.99 |
| Cardiovascular Issues in Pregnancy | Lifetime | 1 | FR 1 | 99.97 |
| Vascular Anomalies and Treatments | Lifetime | 1 | FR 1 | 99.98 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 16 | FR 2 | 99.81 |
| Asthma and respiratory diseases | Lifetime | 55 | FR 2 | 99.81 |
| Systemic Sclerosis and Related Diseases | Lifetime | 31 | FR 4 | 99.60 |
| Liver Disease and Transplantation | Lifetime | 88 | FR 14 | 99.67 |
| Respiratory and Cough-Related Research | Lifetime | 37 | FR 2 | 99.68 |
| Transplantation: Methods and Outcomes | Lifetime | 72 | FR 2 | 99.33 |
| Cardiovascular Function and Risk Factors | Lifetime | 221 | FR 2 | 99.56 |
| Heart Failure Treatment and Management | Lifetime | 143 | FR 4 | 99.43 |
| Eosinophilic Disorders and Syndromes | Lifetime | 98 | FR 8 | 99.02 |
| Allergic Rhinitis and Sensitization | Lifetime | 241 | FR 6 | 98.97 |
| IL-33, ST2, and ILC Pathways | Lifetime | 115 | FR 4 | 98.81 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 533 | FR 24 | 98.54 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 474 | FR 10 | 98.35 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 75 | FR 7 | 97.67 |
| Long-Term Effects of COVID-19 | Lifetime | 532 | FR 28 | 96.18 |
| Medical Imaging and Pathology Studies | Lifetime | 536 | FR 26 | 97.33 |
| Congenital Heart Disease Studies | Lifetime | 732 | FR 13 | 97.51 |
| Eosinophilic Esophagitis | Lifetime | 489 | FR 21 | 97.58 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 572 | FR 16 | 96.27 |
| Renin-Angiotensin System Studies | Lifetime | 465 | FR 23 | 95.93 |
| Delphi Technique in Research | Lifetime | 653 | FR 9 | 89.15 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 1 | FR 1 | 99.96 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 1 | FR 1 | 99.90 |
| Vascular Anomalies and Treatments | 2021-2025 | 1 | FR 1 | 99.73 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 84 | FR 6 | 98.13 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 218 | FR 6 | 98.34 |
| Long-Term Effects of COVID-19 | 2021-2025 | 388 | FR 17 | 96.30 |
| Heart Failure Treatment and Management | 2021-2025 | 186 | FR 5 | 97.78 |
| Congenital Heart Disease Studies | 2021-2025 | 211 | FR 7 | 95.78 |
| Liver Disease and Transplantation | 2021-2025 | 352 | FR 15 | 96.49 |
| Asthma and respiratory diseases | 2021-2025 | 578 | FR 12 | 94.65 |
| Respiratory and Cough-Related Research | 2021-2025 | 181 | FR 6 | 93.81 |
| Medical Imaging and Pathology Studies | 2021-2025 | 380 | FR 15 | 84.66 |
| Transplantation: Methods and Outcomes | 2021-2025 | 768 | FR 38 | 87.83 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 480 | FR 29 | 83.47 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 843 | FR 54 | 82.20 |
| Thermal Regulation in Medicine | 2021-2025 | 394 | FR 10 | 70.92 |
| Renin-Angiotensin System Studies | 2021-2025 | 223 | FR 2 | 67.99 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 580 | FR 28 | 44.21 |
